Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234K Sell
4,765
-98
-2% -$4.56K 0.01% 809
2025
Q4
$212K Buy
4,863
+105
+2% +$4.79K 0.01% 836
2025
Q3
$214K Sell
4,758
-380
-7% -$16.7K 0.01% 815
2025
Q2
$223K Sell
5,138
-200
-4% -$8.9K 0.01% 767
2025
Q1
$246K Sell
5,338
-393
-7% -$16.4K 0.01% 712
2024
Q4
$216K Hold
5,731
0.01% 789
2024
Q3
$232K Sell
5,731
-766
-12% -$28.8K 0.01% 742
2024
Q2
$225K Sell
6,497
-1,440
-18% -$53.1K 0.01% 724
2024
Q1
$298K Buy
7,937
+632
+9% +$22.6K 0.02% 675
2023
Q4
$262K Buy
7,305
+300
+4% +$11.6K 0.02% 663
2023
Q3
$265K Buy
7,005
+303
+5% +$12.3K 0.02% 633
2023
Q2
$273K Hold
6,702
0.02% 653
2023
Q1
$281K Sell
6,702
-816
-11% -$34K 0.02% 627
2022
Q4
$325K Buy
7,518
+534
+8% +$21.1K 0.02% 557
2022
Q3
$262K Sell
6,984
-42
-0.6% -$1.86K 0.02% 613
2022
Q2
$318K Sell
7,026
-363
-5% -$17.1K 0.02% 544
2022
Q1
$352K Sell
7,389
-2,474
-25% -$105K 0.02% 585
2021
Q4
$406K Buy
9,863
+2,111
+27% +$79.5K 0.03% 526
2021
Q3
$268K Buy
7,752
+771
+11% +$26.3K 0.02% 639
2021
Q2
$221K Buy
6,981
+509
+8% +$16.4K 0.02% 699
2021
Q1
$204K Buy
+6,472
New +$194K 0.02% 678
2019
Q3
Sell
-9,248
Closed -$316K 678
2019
Q2
$316K Buy
+9,248
New +$326K 0.04% 402
2016
Q4
Sell
-9,364
Closed -$222K 557
2016
Q3
$222K Sell
9,364
-1,194
-11% -$30K 0.04% 454
2016
Q2
$274K Sell
10,558
-452
-4% -$11.2K 0.05% 385
2016
Q1
$283K Buy
+11,010
New +$247K 0.05% 365
2015
Q3
Sell
-9,093
Closed -$203K 517
2015
Q2
$203K Sell
9,093
-136
-1% -$3.26K 0.03% 465
2015
Q1
$221K Sell
9,229
-3,062
-25% -$75.8K 0.04% 442
2014
Q4
$326K Sell
12,291
-188
-2% -$4.82K 0.06% 364
2014
Q3
$303K Buy
12,479
+2,373
+23% +$55.6K 0.05% 379
2014
Q2
$261K Buy
+10,106
New +$258K 0.04% 416

Other funds holding EXC

Moors & Cabot's EXC Position: Q1 2026 in Review

Moors & Cabot reduced its Exelon (EXC) stake by 2% in Q1 2026, selling an estimated $4.56K and leaving 4,765 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #809.

Moors & Cabot first reported a position in EXC in Q2 2014 and has held it in 30 quarters since. The position peaked at $406K in Q4 2021. 1,281 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Moors & Cabot held 4,765 shares of Exelon worth $234K as of Q1 2026.
  • Moors & Cabot sold 98 Exelon shares in Q1 2026, an estimated $4.56K.
  • Exelon made up 0.01% of Moors & Cabot's portfolio in Q1 2026, its #809 holding.
  • Moors & Cabot first reported a position in Exelon in Q2 2014 and has held it in 30 quarters since.
  • Moors & Cabot's Exelon position peaked at $406K in Q4 2021.
  • 1,281 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.